• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    11/13/24 12:26:41 PM ET
    $ULS
    Precision Instruments
    Health Care
    Get the next $ULS alert in real time by email
    SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1 )*

                

    UL Solutions Inc.


    (Name of Issuer)

    Common Stock


    (Title of Class of Securities)

    903731107


    (CUSIP Number)

    September 30, 2024


    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [X] Rule 13d-1(b)
    [ ] Rule 13d-1(c)
    [ ] Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.)


    CUSIP No. 903731107

    1. NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

    Capital International Investors
    95-1411037
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a) [ ]
    (b) [ ]
    3. SEC USE ONLY
    4. CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

    5. SOLE VOTING POWER 11,410,285
    6. SHARED VOTING POWER 0
    7. SOLE DISPOSITIVE POWER 11,460,011
    8. SHARED DISPOSITIVE POWER 0
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    11,460,011 Beneficial ownership disclaimed pursuant to Rule 13d-4
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    [ ]
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    18.5%
    12. TYPE OF REPORTING PERSON

    IA

    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    


    Item 1.
    (a) Name of Issuer
    UL Solutions Inc.
    (b) Address of Issuer's Principal Executive Offices
    333 Pfingsten Road, Northbrook, IL 60062
    Item 2.
    (a) Name of Person Filing
    Capital International Investors
    (b) Address of Principal Business Office or, if None, Residence
    333 South Hope Street, 55th Fl, Los Angeles, CA 90071
    (c) Citizenship
    N/A
    (d) Title of Class of Securities
    Common Stock
    (e) CUSIP Number
    903731107
    Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
    (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
    (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
    (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
    (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    (e) [X] An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E);
    (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F);
    (g) [ ] A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G);
    (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(J).
    Item 4. Ownership.
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
    (a) Amount Beneficially Owned:
    11,460,011 **
    (b) Percent of Class:
    18.5%
    (c) Number of shares as to which such person has:
    (i) sole power to vote or to direct the vote 11,410,285
    (ii) shared power to vote or to direct the vote 0
    (iii) sole power to dispose or to direct the disposition of 11,460,011
    (iv) shared power to dispose or to direct the disposition of 0
    **Capital International Investors ("CII") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CII's divisions of each of the investment management entities collectively provide investment management services under the name "Capital International Investors." CII is deemed to be the beneficial owner of 11,460,011 shares or 18.5% of the 61,876,949 shares believed to be outstanding.
    Item 5. Ownership of Five Percent or Less of Class.
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ]
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
    Capital Income Builder
    New Perspective Fund
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
    Not Applicable
    Item 8. Identification and Classification of Members of the Group.
    Not Applicable. This schedule is not being filed pursuant to Rule 13d-1(b)(1)(ii)(J) or Rule 13d-1(d).
    Item 9. Notice of Dissolution of Group.

    Not Applicable
    Item 10. Certification.

    By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Capital International Investors
    By: /s/ Jae Won Chung
    Date: November 14, 2024
    Name: Jae Won Chung
    Title: Vice President and Associate Counsel, Fund Business Management Group, Capital Research and Management Company

    Get the next $ULS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ULS

    DatePrice TargetRatingAnalyst
    5/14/2025$71.00Buy → Neutral
    Citigroup
    10/7/2024$60.00Buy
    Citigroup
    7/12/2024$41.00 → $46.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ULS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UL Solutions to Attend Upcoming Investor Conferences

      UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that senior management of the company will participate in the following investor conferences: William Blair 45th Annual Growth Stock Conference, June 3 Stifel 2025 Boston Cross Sector 1x1 Conference, June 4 and Baird 2025 Global Consumer, Technology & Services Conference, June 5. The company's presentation at the William Blair 45th Annual Growth Stock Conference, at 3:00 p.m. EDT (2:00 p.m. CDT) on June 3, will be broadcast live. The webcast can be accessed through the UL Solutions Investor Relations website at ir.ul.com. A replay of the webcast will be available on the website for 30 days a

      5/29/25 4:45:00 PM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Announces Quarterly Dividend

      UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that its board of directors has declared a quarterly dividend of $0.13 per share. The dividend will be paid on June 9 to shareholders of record as of the close of business on May 30. About UL Solutions A global leader in applied safety science, UL Solutions Inc. (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers' product innovation and business growth. The UL Mark serves a

      5/20/25 6:32:00 PM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Launches Advanced Battery Testing Center in Europe

      The UL Solutions Europe Advanced Battery Laboratory in Aachen, Germany, provides testing, simulation and certification services addressing automotive and stationary battery research, safety and performance. UL Solutions Inc. (NYSE:ULS) today announced the opening of its Europe Advanced Battery Testing Laboratory in Aachen, Germany, which will test batteries used in electric vehicles (EVs) and large-scale energy storage systems, significantly expanding the company's battery technology testing capabilities and its European footprint. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513936962/en/Guests celebrate the opening of the

      5/15/25 8:00:00 AM ET
      $ULS
      Precision Instruments
      Health Care

    $ULS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UL Solutions Inc. downgraded by Citigroup with a new price target

      Citigroup downgraded UL Solutions Inc. from Buy to Neutral and set a new price target of $71.00

      5/14/25 8:58:56 AM ET
      $ULS
      Precision Instruments
      Health Care
    • Citigroup resumed coverage on UL Solutions Inc. with a new price target

      Citigroup resumed coverage of UL Solutions Inc. with a rating of Buy and set a new price target of $60.00

      10/7/24 8:45:25 AM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Inc. downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded UL Solutions Inc. from Outperform to Neutral and set a new price target of $46.00 from $41.00 previously

      7/12/24 7:43:51 AM ET
      $ULS
      Precision Instruments
      Health Care

    $ULS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Thaman Michael H

      4 - UL Solutions Inc. (0001901440) (Issuer)

      6/11/25 5:15:54 PM ET
      $ULS
      Precision Instruments
      Health Care
    • SEC Form 4 filed by Director Dollive James P

      4 - UL Solutions Inc. (0001901440) (Issuer)

      6/11/25 5:15:51 PM ET
      $ULS
      Precision Instruments
      Health Care
    • SEC Form 4 filed by Director Susman Sally

      4 - UL Solutions Inc. (0001901440) (Issuer)

      6/11/25 5:15:47 PM ET
      $ULS
      Precision Instruments
      Health Care

    $ULS
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by UL Solutions Inc.

      SCHEDULE 13G/A - UL Solutions Inc. (0001901440) (Subject)

      6/6/25 12:06:11 PM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - UL Solutions Inc. (0001901440) (Filer)

      5/22/25 4:36:38 PM ET
      $ULS
      Precision Instruments
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by UL Solutions Inc.

      SCHEDULE 13G/A - UL Solutions Inc. (0001901440) (Subject)

      5/12/25 10:43:30 AM ET
      $ULS
      Precision Instruments
      Health Care

    $ULS
    Leadership Updates

    Live Leadership Updates

    See more

    $ULS
    Financials

    Live finance-specific insights

    See more

    $ULS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • UL Solutions Inc. Names New Chief Legal Officer

      UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Scott D'Angelo as executive vice president and chief legal officer, effective April 21, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311928632/en/UL Solutions names Scott D'Angelo as executive vice president and chief legal officer (Photo: Business Wire) D'Angelo's appointment fills a vacant role and he joins the company's executive leadership team, reporting to President and CEO Jennifer Scanlon. D'Angelo will oversee the legal, brand integrity, ethics and compliance functions. He most recently served as vice presiden

      3/11/25 9:15:00 AM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Names Chief Business Operations and Innovation Officer

      Alex Dadakis to join UL Solutions leadership team in newly created role UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Alex Dadakis as Executive Vice President, Chief Business Operations and Innovation Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205299962/en/UL Solutions announced the appointment of Alex Dadakis as Executive Vice President, Chief Business Operations and Innovation Officer, effective Jan. 27, 2025. (Photo: Business Wire) Dadakis, who most recently served as Senior Vice President, Global Head of Strategy and Corporate Development at Germany-ba

      12/5/24 4:15:00 PM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Acquires Germany-Based Battery Testing and Simulation Company BatterieIngenieure

      Deal deepens UL Solutions' global expertise in battery performance testing and expands our global EV battery testing footprint. UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced our acquisition of BatterieIngenieure GmbH, a battery testing company based in Aachen, Germany, with expertise in specialized performance testing of cell, small modules and battery systems used in electric vehicles and other applications. The acquisition augments UL Solutions' global battery testing footprint with a laboratory in Europe. BatterieIngenieure provides comprehensive testing, simulation and failure analysis of battery technologies, with distinctive expertise in

      5/22/24 8:30:00 AM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Announces Quarterly Dividend

      UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that its board of directors has declared a quarterly dividend of $0.13 per share. The dividend will be paid on June 9 to shareholders of record as of the close of business on May 30. About UL Solutions A global leader in applied safety science, UL Solutions Inc. (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers' product innovation and business growth. The UL Mark serves a

      5/20/25 6:32:00 PM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Inc. Reports Strong First Quarter 2025 Results

      First Quarter 2025 (Comparisons to First Quarter 2024 unless otherwise noted)1 Strong revenue growth of 5.2% to $705 million, including 7.6% organic growth Net income of $71 million increased 18.3%, Net income margin of 10.1%, expanded 110 basis points Diluted earnings per share of $0.33 increased 17.9%, Adjusted Diluted Earnings Per Share of $0.37 increased 32.1% Adjusted EBITDA of $161 million increased 22.9%, Adjusted EBITDA margin of 22.8% expanded 320 basis points UL Solutions Inc. (NYSE:ULS), a global safety science leader in independent third-party testing, inspection and certification services and related software and advisory offerings, today reported results for the firs

      5/6/25 7:00:00 AM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Inc. Sets Date for First Quarter 2025 Results

      UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the first quarter 2025 before the market opens on Tuesday, May 6. Management will host a webcast and conference call that same day at 8:30 a.m. EDT (7:30 a.m. CDT) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions' website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the conference call will be ava

      4/22/25 7:00:00 AM ET
      $ULS
      Precision Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

      SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

      11/13/24 12:26:41 PM ET
      $ULS
      Precision Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

      SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

      11/12/24 5:49:12 PM ET
      $ULS
      Precision Instruments
      Health Care
    • SEC Form SC 13G filed by UL Solutions Inc.

      SC 13G - UL Solutions Inc. (0001901440) (Subject)

      11/12/24 10:34:15 AM ET
      $ULS
      Precision Instruments
      Health Care